Viewing Study NCT02052193


Ignite Creation Date: 2025-12-25 @ 1:07 AM
Ignite Modification Date: 2025-12-25 @ 11:19 PM
Study NCT ID: NCT02052193
Status: TERMINATED
Last Update Posted: 2022-12-19
First Post: 2014-01-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluation of Photosensitivity in Dabrafenib or Vemurafenib Treated Metastatic Melanoma Patients - a Phase IIa/IIb Study
Sponsor: University Hospital Tuebingen
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-01
Start Date Type: ACTUAL
Primary Completion Date: 2014-12
Primary Completion Date Type: ACTUAL
Completion Date: 2014-12-15
Completion Date Type: ACTUAL
First Submit Date: 2014-01-28
First Submit QC Date: None
Study First Post Date: 2014-01-31
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-12-16
Last Update Post Date: 2022-12-19
Last Update Post Date Type: ACTUAL